PMV Pharmaceuticals (PMVP) Files Form 144 for 2.28M Shares via Themis Trading

Rhea-AI Filing Summary

PMV Pharmaceuticals, Inc. (PMVP) filed a Form 144 notice reporting a proposed sale of 2,283,654 shares of Common Stock through broker Themis Trading LLC with an approximate aggregate market value of $3,653,846.40. The filing lists the number of shares outstanding as 52,990,864 and gives an approximate sale date of 09/10/2025 on NASDAQ.

The securities were acquired on 09/29/2020 in the issuer's Initial Public Offering with cash payment. The filer certifies there were no securities sold in the past three months by the person for whose account the securities will be sold and represents they are unaware of any material nonpublic information about the issuer.

Positive

• Full transaction detail provided: class, broker, exact share count, aggregate value, outstanding shares, and estimated sale date are all disclosed
• Acquisition provenance stated: securities were acquired in the issuer's Initial Public Offering on 09/29/2020 with cash
• No sales in prior three months reported for the person for whose account the securities will be sold

Negative

• Large block scheduled for sale: 2,283,654 shares are being offered (aggregate market value $3,653,846.40), which may be material to some stakeholders
• No 10b5-1 trading plan date provided: the form does not indicate adoption of a written trading plan or its date

Insights

Securities Analyst

TL;DR: Form 144 discloses a planned sale of 2.28M shares via Themis Trading with full acquisition traced to the 2020 IPO.

The filing provides clear transactional detail required under Rule 144: the class, broker name and address, exact share amount, aggregate market value, outstanding shares, and intended sale date. It also documents the acquisition source (IPO) and payment method (cash), which supports Rule 144 eligibility review. The statement that there were no sales in the prior three months and the signers certification about material nonpublic information are standard but important for compliance and market transparency.

Corporate Governance Expert

TL;DR: Disclosure is complete for a Rule 144 notice and includes the signers representation on nonpublic material information.

The form includes the necessary attestations and transaction history that governance reviewers look for when assessing insider or affiliate dispositions. It identifies the broker, sale timing, and the original acquisition via the IPO, enabling stakeholders to verify regulatory compliance. There is no mention of any trading plan or 10b5-1 adoption date on the form.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Themis Trading LLC 10 Townsquare Chatham NJ 07928	2283654	3653846.40	52990864	09/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/29/2020	Initial Public Offering	Issuer			2283654	09/29/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does PMVP's Form 144 report for the proposed sale?

It reports a proposed sale of 2,283,654 shares of Common Stock through Themis Trading LLC with aggregate market value of $3,653,846.40 and an approximate sale date of 09/10/2025.

When and how were the securities for PMVP acquired?

The securities were acquired on 09/29/2020 in the issuer's Initial Public Offering, and payment was made in cash.

Has the filer sold any PMVP securities in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker will handle the PMVP sale listed in Form 144?

The broker named is Themis Trading LLC, located at 10 Townsquare, Chatham, NJ 07928.

Does the filing state whether the signer knows any material nonpublic information?

Yes. By signing the notice the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.